readthroughSign in
CompanyBEAMNasdaqCambridge, MA

Beam Therapeutics Inc.

Beam Therapeutics develops base editing, a gene editing technology designed to make precise single-base changes in DNA without double-stranded breaks.

SCHEDULE 13G/ANov 13Latest SEC filing
Nov 10Latest story